Showing results (291-300 of 475) with videos related to
Sort By:
Pageof 48
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|July 12, 2002
Is human aging still mysterious enough to be left only to scientists?Aubrey D N J de Grey, John W Baynes, David Berd, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 9, 2016
CD4:8 Ratio Above 5 Is Associated With All-Cause Mortality in CMV-Seronegative Very Old Women: Results From the BELFRAIL StudyWim Adriaensen, Graham Pawelec, Bert Vaes, et al.Frontiers in Aging|July 13, 2022
Corrigendum: Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older AdultsChris P Verschoor, Laura Haynes, Graham Pawelec, et al.Clinical Interventions in Aging|November 30, 2007
Immunosupportive therapies in agingTamas Fülöp, Anis Larbi, Katsuiku Hirokawa, et al.Canadian Journal of Physiology and Pharmacology|April 7, 2017
Alteration of high-density lipoprotein functionality in Alzheimer's disease patientsPaméla Camponova, Aurélie Le Page, Hicham Berrougui, et al.Vaccines|January 12, 2021
Antibody and Cell-Mediated Immune Responses Are Correlates of Protection against Influenza Infection in Vaccinated Older AdultsChris P Verschoor, Melissa K Andrew, Mark Loeb, et al.Frontiers in Aging|February 7, 2022
Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older AdultsJanet E McElhaney, Chris P Verschoor, Laura Haynes, et al.Journal of Clinical Immunology|September 10, 2003
Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very oldQin Ouyang, Wolfgang M Wagner, Anders Wikby, et al.Vaccine|July 11, 2017
Frequencies of peripheral immune cells in older adults following seasonal influenza vaccination with an adjuvanted vaccineDavid Goldeck, Heidi Theeten, Fakhri Hassouneh, et al.Vaccine|February 1, 2012
The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccinesJanet E McElhaney, Xin Zhou, H Keipp Talbot, et al.Pageof 48